Allison Hercules Rutledge
About Allison Hercules Rutledge
Allison Hercules Rutledge serves as the Business Director at Magnolia Medical Technologies, where she focuses on improving sepsis testing accuracy and patient safety. She has a background in sales and training, with experience at companies such as Johnson & Johnson, AngioDynamics, and Covidien.
Work at Magnolia Medical Technologies
Allison Hercules Rutledge serves as the Business Director at Magnolia Medical Technologies. She has held this position since 2021, focusing on the Texas and Louisiana regions. In her role, she works with the company's flagship product, Steripath, which is recognized for its ability to reduce blood culture contamination. Steripath has been evaluated in 18 clinical studies and is the only FDA-cleared device for this purpose. Rutledge's responsibilities include driving initiatives that enhance patient safety and antibiotic stewardship through improved sepsis testing accuracy.
Education and Expertise
Allison Rutledge studied at Texas A&M University, where she earned a Bachelor of Business Administration (BBA) with a focus on Marketing. Her studies spanned from 1999 to 2003. This educational background has equipped her with the skills necessary for her roles in sales and business management within the medical technology sector.
Previous Experience in Sales Management
Prior to her current role, Allison Rutledge held several positions in sales management. She worked at Johnson & Johnson as a Territory Sales Representative from 2003 to 2007 in the Tampa/St. Petersburg, Florida area. She then transitioned to Covidien (now Medtronic), where she served as a Senior Territory Sales Manager and Sales Trainer from 2010 to 2016 in the Houston, Texas area. Following that, she worked at AngioDynamics as a Senior Territory Manager and Sales Trainer from 2016 to 2021 in the Houston area.
Focus on Sepsis Testing and Patient Safety
In her current and previous roles, Allison Rutledge has emphasized the importance of establishing a new standard for sepsis testing accuracy. Her efforts are directed towards driving antibiotic stewardship and enhancing patient safety. This focus aligns with her work at Magnolia Medical Technologies, where she contributes to initiatives aimed at improving clinical outcomes through innovative medical devices.
Contributions to Intellectual Property
Allison Rutledge is part of a team at Magnolia Medical Technologies that contributes to the company's intellectual property portfolio. This portfolio includes more than 70 issued patents and over 50 additional patent applications pending. Her involvement in this area underscores her commitment to advancing medical technology and innovation.